"Chronic myeloproliferative disorders (CMD)"
"SEER 5-Year Relative Survival Rates, 2015-2021"
"All Stages By Sex, All Races / Ethnicities, All Ages"

"Sex","5-Year Relative Survival (%)","Lower 95% C.I.","Upper 95% C.I."
"Female","92.7","91.9","93.5"
"Male","87.9","87.0","88.8"


"Data Source:"
"-SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries [https://seer.cancer.gov/registries/terms.html] (excluding Illinois)."
"-Expected Survival Life Tables [https://seer.cancer.gov/expsurvival/] by Socio-Economic Standards."
"Methodology:"
"-The five-year survival rates are calculated using monthly intervals."
"Race/Ethnicity Coding:"
"-For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes [https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/]."
"-Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA)."
"-Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA)."
"Cancer Site Coding:"
"-See SEER*Explorer Cancer Site Definitions [https://seer.cancer.gov/statistics-network/explorer/cancer-sites.html] for details about the cancer site coding used for SEER Incidence data."
Created by https://seer.cancer.gov/statistics-network/explorer/ on Thu Feb 26 2026.